Prospective, Randomized, Multicenter, Controlled Trial (TRIATHRON 1) on a New Antithrombogenic Hydrophilic Dialysis Membrane

INTRODUCTION: Hemodialysis treatment requires anticoagulation to prevent thrombosis of the dialyzer. The Hydrolink(®) (NV series; Toray) has been designed to reduce thrombotic complications by increasing membrane hydrophilic properties. Previous studies have confirmed reduced platelet activation, im...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronco, Claudio, Brendolan, Alessandra, Nalesso, Federico, Zanella, Monica, De Cal, Massimo, Corradi, Valentina, Virzì, Grazia M., Ferrari, Fiorenza, Garzotto, Francesco, Lorenzin, Anna, Karopadi, Aakash N., Sartori, Marco, De Rosa, Silvia, Samoni, Sara, Husain-Syed, Faeq, Spinelli, Alessandra, Neri, Mauro, Villa, Gianluca, Alghisi, Alberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159854/
https://www.ncbi.nlm.nih.gov/pubmed/28569990
http://dx.doi.org/10.5301/ijao.5000608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159854/
https://www.ncbi.nlm.nih.gov/pubmed/28569990
http://dx.doi.org/10.5301/ijao.5000608

Ejemplares similares